Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients.
| Image |  |
|---|---|
| Description | scientific article published on 15 August 2017 |
| Author/s |
author: Herbert Spapen Jean-Louis Vincent |
| Publication date | August 15, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |